trial

Implementing mHealth for Schizophrenia in Community Mental Health Settings

NCTId NCT04147897
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 299 (actual)
Sponsored by University of Washington
Primary completion 2024-09-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
299 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2020-06-16
Primary completion
2024-09-16
Eligibility
ALL · 18 Years · 100 Years

Interventions & indications

Drugs
FOCUS

Sponsors

University of WashingtonLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dror Ben-Zeev, PhDPrincipal Investigator

Sites

8 total
Chehalis, United StatesColville, United StatesEverett, United StatesFederal Way, United StatesPort Angeles, United StatesSeattle, United StatesSpokane, United StatesYakima, United States

Facts & assertions

4 sourced
Enrollment
299
Phase
NA
Primary Completion Date
2024-09-16
Status
COMPLETED
relationships
The graph out of here
drug
FOCUS
drug
lead_sponsor
University of Washington
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Dror Ben-Zeev, PhD
person